|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/20 | (2006.01) |
| A61K 31/4162 | (2013.01) | ||
| A61K 31/397 | (2006.01) | ||
| A61K 9/2013 | (2013.01) | ||
| A61K 31/41 | (2006.01) | ||
| A61K 9/2054 | (2013.01) | ||
| A61K 31/4162 | (2006.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 35/02 | (2006.01) |
| (11) | Number of the document | 4221704 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21876583.2 |
| Date of filing the European patent application | 2021-10-01 | |
| (97) | Date of publication of the European application | 2023-08-09 |
| (45) | Date of publication and mention of the grant of the patent | 2025-09-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2021/053141 |
| Date | 2021-10-01 |
| (87) | Number | WO 2022/072811 |
| Date | 2022-04-07 |
| (30) | Number | Date | Country code |
| 202063086353 P | 2020-10-01 | US |
| (72) |
TAPPER, Amy , US
CELATKA, Cassandra , US
SOULLIAC, Patricia , US
VED, Parag , US
VORA, Namrata , US
|
| (73) |
Imago Biosciences Inc. ,
2729 Debbie Court, San Carlos, CA 94070,
US
|
| (54) | PHARMACEUTICAL FORMULATIONS FOR TREATING DISEASES MEDIATED BY KDM1A |
| PHARMACEUTICAL FORMULATIONS FOR TREATING DISEASES MEDIATED BY KDM1A |